Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives

Review Gastroenterology & Hepatology

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

Zobair M. Younossi et al.

Summary: A comprehensive meta-analysis was conducted to assess the global and regional prevalence, incidence, and mortality of non-alcoholic fatty liver disease (NAFLD). The results showed that the global prevalence of NAFLD is 30% and increasing, highlighting the need for urgent and comprehensive strategies to raise awareness and address NAFLD on local, regional, and global levels.

HEPATOLOGY (2023)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

It is time to expand the fatty liver disease community of practice

Jeffrey V. Lazarus et al.

HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

Jeffrey V. Lazarus et al.

Summary: Although NAFLD is a pressing public health problem, no country was found to be well prepared to address it. A comprehensive public health response is lacking in all 102 countries, with approximately one-third scoring zero on the NAFLD policy preparedness index and no country scoring over 50/100. Policies and strategies to address NAFLD at the national and global levels are urgently needed.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

Tom H. Karlsen et al.

LANCET (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

Jeffrey Lazarus et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects a significant portion of the global adult population, but has received little attention from the global public health community. This has led to a lack of inclusion of NAFLD in national and international strategies and policies for non-communicable diseases, highlighting the need for a more comprehensive public health response to the disease.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Michael H. Le et al.

Summary: Using a Bayesian approach, the study forecasts that by 2040, over half of the adult population will have nonalcoholic fatty liver disease (NAFLD). The largest increases in prevalence are expected in women, smokers, and those without metabolic syndrome. Efforts are needed to increase awareness of NAFLD and find long-term solutions to address the driving factors of the disease.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Theo Vos et al.

LANCET (2020)

添加到收藏夹

Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives

相关参考文献

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

It is time to expand the fatty liver disease community of practice

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

Advancing the global public health agenda for NAFLD: a consensus statement

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

导出引文

分享论文